Aardvark Therapeutics, Inc. Common Stock ( AARD) - Stock Earnings
AARD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
AARD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -17.6 million USD | — USD |
| 2026Q1 | -21.6 million USD | — USD |
| 2026Q2 | -14.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AARD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.2 million USD | — USD |
| 2024 | -20.6 million USD | — USD |
| 2025 | -57.6 million USD | — USD |
| 2026 Est. | — | — |
AARD
Price: $4.38
52 week price:
Earnings Per Share: -2.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 113.5 million